[…] received throughout the year from fellow FSH Society members that demonstrate how they won’t let FSHD stand in their way. Your support is life-changing to those in the Society – and […]
Looking Back on a Year Full of Strength, Part 3 of 3
Vita Therapeutics’ cell-based therapy update
[…] and plans to develop muscle stem cells that evade the immune system by June Kinoshita, FSHD Society Hot off the press is this news that Vita Therapeutics shared at the […]
Feeling Fit with Lonwabo Nene
Disclaimer: Information provided by the FSHD Society does not imply an endorsement of any of the drugs, procedures, treatments, or products discussed. Please consult your own healthcare provider about any […]
Promising findings from Avidity’s myotonic dystrophy trial
[…] for the disease. DM1 is a genetic, muscle-damaging disease that affects children and adults. Like FSHD, myotonic dystrophy weakens muscles in the face, hands, feet, and other areas of the […]
aTyr Pharma to advance Resolaris™ clinical programs
[…] a Phase 1b/2 clinical trial of its experimental therapy Resolaris in adult facioscapulohumeral muscular dystrophy ( FSHD) patients. While the number of patients in the study is small, the company stated […]